Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAYREVILLE, N.J.--(BUSINESS WIRE)--Vertical Pharmaceuticals, Inc. today announced that Vertical and Nautilus Neurosciences have entered into a co-promotion agreement for Lorzone™ (chlorzoxazone tablets, USP), a safe, effective, and fast-acting muscle relaxant that is not associated with significant sedation or drowsiness.
Under the terms of the agreement, Vertical and Nautilus will co-promote Lorzone™ with a combined nationwide sales force of 115 sales representatives in the US market. Nautilus will focus product promotion efforts on their current target list specializing in the neurology field.
“We are extremely excited about this co-promote opportunity with Nautilus as they bring a highly regarded and professional sales force to our existing commercialization efforts in support of Lorzone,” said Greg Voyles, Vertical’s Chief Operating Officer. “With the addition of the Nautilus sales force we can expand our promotional reach into a new marketplace and give prescribers an opportunity to offer their patients an important option in this therapeutic category.”
“We look forward to working with our partners at Vertical to launch Lorzone to our customers,” said William Maichle, Chief Executive Officer, Nautilus Neurosciences. “We are committed to providing valuable, life-changing therapies to our patients and healthcare providers and feel Lorzone is consistent with the Nautilus mission.”
About Lorzone™ (chlorzoxazone tablets, USP)
Lorzone™ (chlorzoxazone tablets, USP) is indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is available in a 375mg tablet and a 750mg tablet that is bisected on one side and trisected on the reverse side to provide unique dosing flexibility.
Safety Information
Chlorzoxazone-containing products are usually well tolerated. Drowsiness, dizziness, light-headedness, malaise, or overstimulation may be noted by an occasional patient. The concomitant use of alcohol or other central nervous system depressants may have an additive effect.
Lorzone™ is contraindicated in patients with known intolerance to the drug. Lorzone™ should be used with caution in patients with known allergies or with a history of allergic reactions to drugs. If any symptoms suggestive of liver dysfunction are observed, the drug should be discontinued.
For complete prescribing information and important safety information please visit www.verticalpharma.com/lorzone.
About Vertical Pharmaceuticals, Inc.
Vertical Pharmaceuticals, Inc. is a privately owned pharmaceutical company founded in 2003 with a clear focus in mind – to develop, market, and acquire products offering therapeutic benefits for patients and healthcare providers. The Company specializes in Women’s Health and Pain Management. Our prescription medications are marketed by our dedicated nationwide sales force throughout the US market. Achieving patient satisfaction is fundamental to our business. We are committed to marketing trusted medicines, making a difference in people’s lives with products of the highest quality.
For more information, please visit the company’s website at www.verticalpharma.com.
About Nautilus Neurosciences
Nautilus Neurosciences, Inc. is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with medically relevant products and services that directly benefit those affected by neurologic disorders. Nautilus is sponsored by Tailwind Capital and Galen Partners.
For more information, please visit the company’s website at www.nautilusneurosciences.com.
Contacts
Vertical Pharmaceuticals, Inc.
Greg Voyles, 732-721-0070
Chief Operating Officer
or
Nautilus Neurosciences
William Maichle, 908-393-7800
Chief Executive Officer
Help employers find you! Check out all the jobs and post your resume.
